( NASDAQ-NMS:SVA )

News from Sinovac Biotech Ltd. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 15, 2016, 06:00 ET Sinovac to Host Conference Call to Report Third Quarter 2016 Unaudited Financial Results

Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited...


Nov 07, 2016, 06:00 ET Sinovac Announces Results of 2016 Annual General Meeting of Shareholders

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced the results of the Company's 2016...


Oct 19, 2016, 06:00 ET Sinovac Product Pipeline News

BEIJING, Oct. 19, 2016 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today...


Oct 26, 2015, 06:00 ET Sinovac Receives Clinical Trial Approval for Varicella Vaccine Candidate

Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced that one of its subsidiaries, Sinovac...


Sep 14, 2015, 06:00 ET Sinovac Receives Tender to Supply Seasonal Flu Vaccine in Beijing

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that it has been selected by the...


Sep 10, 2015, 06:00 ET Sinovac to Participate in Morgan Stanley Global Healthcare Conference

BEIJING, Sept. 10, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today...


Mar 18, 2015, 06:00 ET Sinovac to Participate in China Medical and Healthcare Investment Conference

Sinovac Biotech Ltd.(NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced that the Company will participate in...


Mar 17, 2015, 06:00 ET Sinovac Provides Updates on Pipeline Vaccines

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today provided updates on the Company's pipeline...


Nov 14, 2014, 16:30 ET Sinovac Reports Unaudited Third Quarter Financial Results

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced its unaudited financial results for...


Nov 05, 2014, 04:00 ET Sinovac to Host Conference Call to Report Third Quarter 2014 Unaudited Financial Results

BEIJING, Nov. 5, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today...


Oct 21, 2014, 06:06 ET Sinovac to Participate in Jefferies 4th Annual Asia Summit

 Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that the Company's management...


Sep 05, 2014, 06:00 ET Sinovac Announces New Presentation Time for Aegis Healthcare & Technology Conference

Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced a new presentation time for the Aegis...


Sep 02, 2014, 06:00 ET Sinovac to Participate in Upcoming Investor Conferences

 Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that the Company's management...


Aug 27, 2014, 06:00 ET Sinovac Announces Results of 2014 Annual General Meeting of Shareholders

Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced the results of the Company's 2014...


Aug 14, 2014, 12:49 ET Sinovac Reports Unaudited Second Quarter Financial Results

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited second quarter and...


Jul 25, 2014, 05:00 ET Sinovac to Host Conference Call to Report Second Quarter 2014 Unaudited Financial Results

Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited...


Jul 23, 2014, 06:00 ET Sinovac Receives Beijing CDC Tender to Supply Seasonal Flu Vaccine Anflu

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that it has been selected by the...


Jul 21, 2014, 06:00 ET Sinovac Receives Tender to Supply Inactivated Hepatitis A Vaccine Healive in Beijing Under Expanded Immunization Program

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that it has been selected by the...


Jul 14, 2014, 06:00 ET Sinovac Schedules 2014 Annual Meeting of Shareholders

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that it will hold its 2014 Annual...


Jun 25, 2014, 06:00 ET Sinovac Announces Favorable Reduction in Value Added Tax Rate

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that the value added tax (or "VAT")...


May 21, 2014, 18:00 ET Sinovac Reports Unaudited First Quarter 2014 Financial Results

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited first quarter...


May 12, 2014, 06:00 ET Sinovac to Host Conference Call to Report First Quarter 2014 Unaudited Financial Results

Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited...


Apr 28, 2014, 06:09 ET Sinovac Enters Technology Transfer Agreement with Intravacc to Develop and Commercialize Sabin Inactivated Polio Vaccine (sIPV)

Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China that focuses on the research, development,...


Mar 19, 2014, 18:00 ET Sinovac Reports Unaudited Fourth Quarter and Full Year 2013 Financial Results

Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited fourth quarter and...


Jan 29, 2014, 07:07 ET Sinovac Files Clinical Trial Application with CFDA for its Proprietary Vaccine against Avian Influenza A(H7N9) Virus

Sinovac Biotech Ltd. (Nasdaq:SVA), a leading provider of biopharmaceutical products in China, announced today that it has submitted a Clinical...